WuXi XDC Cayman (FRA:L74) Total Debt per Share: €0.09 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:L74 WuXi XDC Cayman Inc FRA:L74
55 GF Score
Price €7.50
! 3 Warning Signs
View Full Analysis

What is WuXi XDC Cayman Total Debt per Share?

WuXi XDC Cayman FRA:L74 -4.46% 55 Total Debt per Share is €0.09 as of Dec. 2025. GuruFocus rates FRA:L74 with a GF Score™ of 55/100. The stock has 3 warning signs investors should review.

€0.09 (As of Dec. 2025)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. WuXi XDC Cayman's Total Debt Per Share for the quarter that ended in Dec. 2025 was €0.09.

WuXi XDC Cayman Total Debt per Share Historical Data

* Premium members only.

The historical data trend for WuXi XDC Cayman's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WuXi XDC Cayman Total Debt per Share Chart

WuXi XDC Cayman Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial 0.00 0.01 0.00 0.05 0.09

WuXi XDC Cayman Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.01 0.05 0.10 0.09 0.05
FRA:L74
55GF Score
WuXi XDC Cayman Inc FRA:L74
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

WuXi XDC Cayman Total Debt per Share Calculation

WuXi XDC Cayman's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(3.9+102.7)/1,255.2
=0.08

WuXi XDC Cayman's Total Debt Per Share for the quarter that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(3.9+102.7)/1,255.2
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of €0.09 mean?
WuXi XDC Cayman (FRA:L74) has a Total Debt per Share of €0.09 as of Dec. 2025. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on WuXi XDC Cayman and its competitors.
Is WuXi XDC Cayman's Total Debt per Share too high?
WuXi XDC Cayman's current Total Debt per Share is €0.09. Overall, WuXi XDC Cayman has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does WuXi XDC Cayman's Total Debt per Share compare to TMO and DHR?
WuXi XDC Cayman's Total Debt per Share of €0.09 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Medical Diagnostics & Research company?
A good Total Debt per Share depends on the Medical Diagnostics & Research industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on WuXi XDC Cayman and its competitors. WuXi XDC Cayman's current Total Debt per Share is €0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WuXi XDC Cayman stock overvalued right now?
WuXi XDC Cayman (FRA:L74) has a current Total Debt per Share of €0.09. The current Total Debt per Share is €0.09. WuXi XDC Cayman's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For WuXi XDC Cayman (FRA:L74), the current Total Debt per Share is €0.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

WuXi XDC Cayman Business Description

Other Exchanges 02268:Hong Kong
Address No. 11 Xinhui Ring Road, Xinwu, Jiangsu Province, Wuxi, CHN
WuXi XDC Cayman Inc is a CRDMO focused on the ADC and broader bioconjugate market and is the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, it offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development, and manufacturing. The company provides these services from proximately located laboratories and manufacturing facilities, resulting in the reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development, and manufacturing platform, its mission is to continuously enhance its platform and propel and transform the development of the bioconjugate industry.
55GF Score

Get the complete analysis for FRA:L74

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.50
Price